CRL

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change +1.72
Percentage change 1.15	%

Peers: IQV LDOS MEDP CVS PFE ILMN BMY LH MRK

| Held by: VTI VOO VB RSP VBR SPY IVV XLV IBB IWR

Scroll to Statements

Index	S&P 500	P/E	-	EPS (ttm)	-0.65	Insider Own	1.25%	Shs Outstand	49.12M	Perf Week	2.95%
Market Cap	7.45B	Forward P/E	14.70	EPS next Y	10.32	Insider Trans	0.39%	Shs Float	48.50M	Perf Month	10.19%
Enterprise Value	10.26B	PEG	-	EPS next Q	2.50	Inst Own	109.94%	Short Float	5.37%	Perf Quarter	-2.46%
Income	-31.56M	P/S	1.85	EPS this Y	-6.51%	Inst Trans	1.09%	Short Ratio	1.65	Perf Half Y	-18.55%
Sales	4.02B	P/B	2.33	EPS next Y	7.02%	ROA	-0.40%	Short Interest	2.61M	Perf YTD	-17.81%
Book/sh	65.04	P/C	32.36	EPS next 5Y	2.93%	ROE	-0.92%	52W High	254.15 -40.30%	Perf Year	-26.60%
Cash/sh	4.69	P/FCF	13.23	EPS past 3/5Y	-70.29% -47.65%	ROIC	-0.51%	52W Low	91.86 65.17%	Perf 3Y	-31.21%
Dividend Est.	-	EV/EBITDA	11.25	Sales past 3/5Y	4.59% 9.09%	Gross Margin	30.43%	Volatility	2.88% 3.08%	Perf 5Y	-13.30%
Dividend TTM	-	EV/Sales	2.55	EPS Y/Y TTM	-107.31%	Oper. Margin	12.80%	ATR (14)	4.77	Perf 10Y	103.04%
Dividend Ex-Date	-	Quick Ratio	1.16	Sales Y/Y TTM	-2.16%	Profit Margin	-0.78%	RSI (14)	61.76	Recom	2.63
Dividend Gr. 3/5Y	- -	Current Ratio	1.43	EPS Q/Q	-64.42%	SMA20	3.16%	Beta	1.49	Target Price	152.93
Payout	0.00%	Debt/Eq	0.94	Sales Q/Q	-2.71%	SMA50	11.87%	Rel Volume	0.54	Prev Close	150.01
Employees	20100	LT Debt/Eq	0.93	Earnings	May 07 BMO	SMA200	-9.32%	Avg Volume	1.58M	Price	151.73
IPO	Jun 23, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	12.73% 4.48%	Trades		Volume	857,007	Change	1.15%

Date	Action	Analyst	Rating Change	Price Target Change
May-23-25	Upgrade	Redburn Atlantic	Neutral → Buy	$182
May-14-25	Upgrade	TD Cowen	Hold → Buy	$179
May-08-25	Upgrade	Evercore ISI	In-line → Outperform	$170
Mar-21-25	Downgrade	Goldman	Buy → Neutral	$190 → $170
Mar-04-25	Upgrade	Citigroup	Sell → Neutral	$155 → $175
Mar-03-25	Upgrade	Redburn Atlantic	Sell → Neutral	$188
Jan-22-25	Downgrade	William Blair	Outperform → Mkt Perform
Jan-17-25	Downgrade	UBS	Buy → Neutral	$250 → $185
Nov-18-24	Downgrade	CLSA	Hold → Underperform	$164
Nov-07-24	Upgrade	CLSA	Underperform → Hold	$205
Oct-23-24	Initiated	CLSA	Underperform	$167
Oct-14-24	Initiated	Redburn Atlantic	Sell
Oct-07-24	Downgrade	Evercore ISI	Outperform → In-line	$225 → $190
Oct-02-24	Downgrade	BofA Securities	Buy → Neutral	$250 → $215
Oct-01-24	Downgrade	Citigroup	Neutral → Sell	$215 → $175
Aug-08-24	Downgrade	Robert W. Baird	Outperform → Neutral	$239 → $191
Aug-08-24	Downgrade	JP Morgan	Overweight → Neutral	$270 → $205
Jun-28-24	Downgrade	Argus	Buy → Hold
Jun-07-24	Initiated	Mizuho	Neutral	$235
Jun-06-24	Initiated	Goldman	Buy	$290

Show Previous Ratings

Jun-25-25 11:34AM	Is Charles River Laboratories Stock Underperforming the S&P 500? (Barchart)
Jun-18-25 12:02AM	3 Reasons to Sell CRL and 1 Stock to Buy Instead (StockStory)
Jun-16-25 08:00AM	Charles River Announces Endosafe® Cartridge Recycling Program, Strengthening Sustainability Commitment (Business Wire)
Jun-11-25 05:28AM	CRL Q1 Earnings Call: Regulatory Changes and Market Stabilization Shape Outlook (StockStory)
Jun-10-25 03:48PM	Megacap stocks aren't all up in 2025. But this chart shows they've trounced the S&P 500's smallest equities. (MarketWatch)
11:31AM	Loading…
Jun-06-25 11:31AM	Why Is Charles River (CRL) Down 0.1% Since Last Earnings Report? (Zacks)
Jun-02-25 08:12AM	Charles River Stock May Gain From Extended CHDI Research Deal on HD (Zacks)
08:00AM	Charles River Laboratories to Present at William Blair and Jefferies Conferences (Business Wire)
May-30-25 12:46AM	Charles River Laboratories International, Inc. (CRL): A Bull Case Theory (Insider Monkey)
May-28-25 08:00AM	Charles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntingtons Disease Research (Business Wire)
May-24-25 03:55AM	Redburn Upgrades Charles River Laboratories (CRL) to Buy, Cuts PT (Insider Monkey)
May-20-25 08:53AM	Should You Continue to Hold Charles River Stock in Your Portfolio? (Zacks)
May-19-25 11:34PM	Drug Development Inputs & Services Stocks Q1 Results: Benchmarking Charles River Laboratories (NYSE:CRL) (StockStory)
May-13-25 09:16AM	Understanding Charles River (CRL) Reliance on International Revenue (Zacks)
08:00AM	Charles River Laboratories to Present at Bank of America Health Care Conference (Business Wire)
07:00AM	Loading…
May-09-25 07:00AM	Eli Lilly extends Purdue alliance; EMA investigates Valneva shot (BioPharma Dive)
May-08-25 03:18AM	Charles River Laboratories International Inc (CRL) Q1 2025 Earnings Call Highlights: Navigating ... (GuruFocus.com)
May-07-25 09:34PM	Analyst Report: Charles River Laboratories International, Inc. (Morningstar Research) +18.68%
05:19PM	S&P 500 Gains & Losses Today: Stocks Gain in Volatile Session as Markets React to Fed Meeting, Trump Trade Comments (Investopedia)
04:22PM	Charles River to initiate a review amid Elliott stake - Is a sale next? (Investing.com)
02:47PM	Charles river raises 2025 guidance with focus on NAMs and cost optimization (Seeking Alpha)
02:46PM	Charles River Laboratories International, Inc. (CRL) Q1 2025 Earnings Call Transcript (Seeking Alpha)
12:17PM	Charles River Stock Is Having Its Best Day in 13 Years. A Board Shake-Up and Business Review Will Help. (Barrons.com)
11:51AM	Top Stock Moves Now: Charles River Labs, Disney, Supermicro, and More (Investopedia)
10:23AM	Charles River Labs Stock Soars as Firm Shakes Up Board, Launches Review (Investopedia)
09:51AM	Charles River announces strategic review including 'examination of various alternatives' (Seeking Alpha)
09:35AM	CRL Q1 Earnings & Revenues Beat Estimates, Stock Rises, '25 View Up (Zacks)
09:30AM	Compared to Estimates, Charles River (CRL) Q1 Earnings: A Look at Key Metrics (Zacks)
09:04AM	Charles River surges after Q1 beat, guidance raise (Seeking Alpha)
08:15AM	Charles River Laboratories (CRL) Beats Q1 Earnings and Revenue Estimates (Zacks)
07:13AM	Loading…
07:13AM	Charles River: Q1 Earnings Snapshot (Associated Press Finance)
07:01AM	Charles River Laboratories Announces First-Quarter 2025 Results (Business Wire)
07:00AM	Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value (Business Wire)
06:08AM	Charles River to add new directors, review business in agreement with Elliott (Reuters)
May-05-25 12:50PM	Analyst Report: Charles River Laboratories International, Inc. (Morningstar Research)
May-01-25 10:01AM	Progyny (PGNY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
09:15AM	ClearBridge All Cap Growth Portfolios Q1 2025 Commentary (Seeking Alpha)
Apr-30-25 07:39PM	Charles River Laboratories International, Inc. (CRL): Among the Worst Performing Stocks in S&P 500 So Far in 2025 (Insider Monkey)
11:45AM	The Davenport Insider Buying Fund Q1 2025 Commentary (Seeking Alpha)
10:01AM	Analysts Estimate Charles River Laboratories (CRL) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-29-25 08:00AM	Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort (Business Wire)
Apr-28-25 09:12AM	Here's How Charles River is Placed Just Ahead of Q1 Earnings (Zacks)
Apr-22-25 10:01AM	Upslope Capital Management Sold Charles River (CRL) Due to Thesis Break (Insider Monkey)
08:00AM	Charles River Leverages Advanced Technology to Expedite Oncology Drug Discovery and Development (Business Wire)
Apr-17-25 11:01PM	Charles River Laboratories International, Inc. (CRL): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025 (Insider Monkey)
Apr-16-25 07:55AM	The 2 Worst Performing S&P 500 Stocks YTD: Buy, Sell, or Avoid? (MarketBeat)
Apr-15-25 04:30PM	Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call (Business Wire)
10:35AM	Upslope Capital's Q1 2025 Investor Letter (Seeking Alpha)
08:26AM	Strength Seen in Charles River (CRL): Can Its 6.9% Jump Turn into More Strength? (Zacks)
Apr-12-25 08:15AM	Charles River Gets Hit By The FDA, Too Early To Bet On A Comeback (Seeking Alpha)
07:50AM	What Moved Markets This Week (Seeking Alpha)
Apr-11-25 02:36PM	Charles River Faces Significant Regulatory And Macro Pressures (Seeking Alpha)
05:46AM	Why Charles River Laboratories International, Inc. (CRL) Went Down On Thursday? (Insider Monkey)
Apr-10-25 08:43PM	Analyst Report: Charles River Laboratories International, Inc. (Morningstar Research) -28.13%
12:10PM	Will Charles River (CRL) Beat Estimates Again in Its Next Earnings Report? (Zacks)
09:05AM	Bausch + Lomb (BLCO) Moves 13.9% Higher: Will This Strength Last? (Zacks)
Apr-03-25 07:44PM	Analyst Report: Charles River Laboratories International, Inc. (Morningstar Research) -5.56%
Mar-31-25 09:20AM	Charles River & Valo Health's Logica Identifies New Lupus Drug Candidate (Zacks)
Mar-25-25 08:00AM	Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica, an AI-Powered Drug Discovery Platform (Business Wire)
Mar-24-25 12:34PM	Why Charles River Laboratories International, Inc. (CRL) is Among the Best Diagnostics Stocks to Invest in Right Now (InsiderMonkey)
Mar-21-25 11:30AM	Charles River (CRL) Up 1.9% Since Last Earnings Report: Can It Continue? (Zacks)
Mar-20-25 05:02AM	3 Reasons CRL is Risky and 1 Stock to Buy Instead (StockStory)
Mar-11-25 08:00AM	Charles River Laboratories to Present at Barclays Global Healthcare Conference (Business Wire)
Mar-05-25 04:01AM	Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4 (StockStory)
Feb-28-25 09:35AM	Bell Global Equities Sold Charles River Laboratories International (CRL) Due To Its Potential For On-going Risk To Earnings (Insider Monkey)
Feb-25-25 11:30AM	SGH and Charles River team up for CGMP cell banking services (Hospital Management)
08:00AM	Charles River Announces Agreement with Singapore General Hospital (Business Wire)
Feb-24-25 09:15AM	Deciphering Charles River (CRL) International Revenue Trends (Zacks)
08:03AM	UFP Technologies (UFPT) Reports Q4: Everything You Need To Know Ahead Of Earnings (StockStory)
Feb-20-25 02:04AM	Charles River Laboratories International Inc (CRL) Q4 2024 Earnings Call Highlights: Navigating ... (GuruFocus.com)
12:11AM	Q4 2024 Charles River Laboratories International Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-19-25 06:08PM	Analyst Report: Charles River Laboratories International, Inc. (Morningstar Research) +6.87%
04:58PM	Analyst Sees Charles River As Preclinical Leader But Maintains Neutral Stance (Benzinga)
09:30AM	Compared to Estimates, Charles River (CRL) Q4 Earnings: A Look at Key Metrics (Zacks)
08:10AM	Charles River Laboratories (CRL) Tops Q4 Earnings and Revenue Estimates (Zacks)
07:27AM	Charles River Laboratories (NYSE:CRL) Posts Better-Than-Expected Sales In Q4 (StockStory)
07:22AM	Charles River: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance (Business Wire)
Feb-18-25 08:03AM	Earnings To Watch: Charles River Laboratories (CRL) Reports Q4 Results Tomorrow (StockStory)
Feb-17-25 09:16AM	Gear Up for Charles River (CRL) Q4 Earnings: Wall Street Estimates for Key Metrics (Zacks)
Feb-12-25 10:00AM	Charles River Laboratories (CRL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Feb-11-25 06:41PM	Charles River Laboratories International, Inc. (CRL) Expands AI-Powered Digital Pathology Collaboration with Deciphex (Insider Monkey)
08:00AM	Charles River and Deciphex Extend Global Partnership to Expand Digital Pathology Offering with Exclusive Image Management Solutions (Business Wire)
Jan-28-25 04:30PM	Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call (Business Wire)
Jan-23-25 07:16AM	Charles River downgraded to Market Perform from Outperform at William Blair (TipRanks)
Jan-21-25 09:09AM	RiverWater Partners Sustainable Value Strategy Trimmed its Investment in Charles River Laboratories (CRL) (Insider Monkey)
08:27AM	What Makes Charles River Labs (CRL) an Investment Bet? (Insider Monkey)
08:00AM	Charles River Expands Apollo Ecosystem, Offering Bespoke Client Experiences (Business Wire)
Jan-17-25 07:22AM	Charles River and Akron link to integrate cytokines into cell therapy (Pharmaceutical Technology)
Jan-16-25 08:00AM	Charles River and Akron Bio Announce Collaboration to Enhance Operations with Integration of CGMP Materials into Cell Therapy Platform (Business Wire)
Jan-15-25 08:07PM	Analyst Report: Charles River Laboratories International, Inc. (Morningstar Research)
04:13PM	Charles River CEO reveals drop in 2025 revenue outlook at JP Morgan (Pharmaceutical Technology)
Jan-14-25 11:56AM	Top Stock Movers Now: United Rentals, KB Home, Eli Lilly, and More (Investopedia) -6.34%
Jan-13-25 08:00AM	Charles River Laboratories to Present at J.P. Morgan Healthcare Conference (Business Wire)
Jan-07-25 08:00AM	Deciphex Secures $32.3M Series C to Address Global Pathology Shortage (Business Wire)
Dec-06-24 11:31AM	Why Is Charles River (CRL) Down 8.9% Since Last Earnings Report? (Zacks)
Dec-05-24 08:00AM	Charles River Introduces Global Biotech Incubator Program (Business Wire)
Dec-02-24 08:00AM	Charles River Laboratories to Present at Evercore ISI Investor Conference (Business Wire)
Nov-11-24 09:15AM	Charles River (CRL) International Revenue in Focus: Trends and Expectations (Zacks)
08:00AM	Charles River Laboratories to Present at UBS and Jefferies Conferences (Business Wire)

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The Research Models and Services segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The Discovery and Safety Assessment segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
WALLMAN RICHARD F	Former Director	Jun 23 '25	Proposed Sale	137.50	4,000	550,000		Jun 25 04:34 PM
MASSARO GEORGE	Director	May 15 '25	Sale	137.57	140	19,260	5,575	May 16 04:29 PM
MASSARO GEORGE	Director	May 14 '25	Sale	140.73	140	19,703	5,715	May 15 04:41 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	May 13 '25	Sale	145.41	500	72,705	19,513	May 15 04:38 PM
MASSARO GEORGE	Director	May 14 '25	Proposed Sale	140.73	280	39,405		May 14 04:05 PM
Joseph LaPlume	Officer	May 13 '25	Proposed Sale	144.32	500	72,160		May 13 03:33 PM
FOSTER JAMES C	Chairman, President and CEO	Feb 20 '25	Buy	165.01	6,075	1,002,436	183,639	Feb 21 04:41 PM
Girshick Birgit	Corporate Executive VP & COO	Feb 20 '25	Buy	164.63	1,514	249,250	55,058	Feb 21 04:38 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	Feb 20 '25	Sale	162.50	4,400	715,000	20,013	Feb 21 04:36 PM
Joseph LaPlume	Officer	Feb 20 '25	Proposed Sale	165.00	4,400	726,000		Feb 20 12:36 PM
WALLMAN RICHARD F	Director	Nov 07 '24	Sale	216.12	6,621	1,430,918	12,386	Nov 12 04:38 PM
WALLMAN RICHARD F	Director	Nov 07 '24	Sale	216.50	1,000	216,500	0	Nov 12 04:38 PM
WALLMAN RICHARD F	Director	Nov 07 '24	Proposed Sale	216.01	12,161	2,626,923		Nov 07 04:23 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	Aug 08 '24	Sale	199.36	1,780	354,861	22,521	Aug 12 04:13 PM
Joseph LaPlume	Officer	Aug 08 '24	Proposed Sale	196.63	1,780	350,000		Aug 08 01:34 PM
FOSTER JAMES C	Chairman, President and CEO	Aug 01 '24	Sale	250.00	25,000	6,250,000	188,251	Aug 05 04:04 PM
FOSTER JAMES C	Officer	Aug 01 '24	Proposed Sale	250.00	25,000	6,250,000		Aug 01 04:07 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Charles River Laboratories International Inc

Upgrade your FINVIZ experience